Chemical formula: C₂₂H₂₈BrN Molecular mass: 306.472 g/mol
Prifinium is an anticholinergic preferably acting at muscarinic receptors in the gastrointestinal tract. Prifinium’s mechanism of action is believed to be due to its activity as an antispasmodic agent. It is used primarily in the treatment of irritable bowel syndrome.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A03AB18 | Prifinium bromide | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AB Synthetic anticholinergics, quaternary ammonium compounds |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| FRIDIAL Oral solution | MPI, EU: SmPC |
Prifinium is an active ingredient of these brands:
South Africa (ZA)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
